首页 | 本学科首页   官方微博 | 高级检索  
     


Use of the Twelve-Gene Recurrence Score for Ductal Carcinoma in Situ and Its Influence on Receipt of Adjuvant Radiation and Hormonal Therapy
Authors:Piltin  Mara A.  Hoskin  Tanya L.  Day  Courtney N.  Shumway  Dean A.  Habermann  Elizabeth B.  Davis  John  Boughey  Judy C.
Affiliation:1.Department of Surgery, Mayo Clinic, Rochester, MN, USA
;2.Department of Health Science Research and Clinical Statistics, Mayo Clinic, Rochester, MN, USA
;3.Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA
;
Abstract:Annals of Surgical Oncology - Tumor genomic prognostic assays estimate 10-year local recurrence risk in ductal carcinoma in situ (DCIS) and can guide treatment decisions. This study aimed to...
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号